急性心肌梗死患者特征、治疗与6个月结局的20年变化:FAST-MI项目1995至2015年
该研究基于法国FAST-MI项目5个每5年一次、每次为期1个月的注册登记,纳入1995至2015年间14 423例急性心肌梗死患者(59%为STEMI)。结果显示,20年间STEMI患者6个月死亡率从17.2%降至2015年的5.3%,NSTEMI患者从17.2%降至2015年的6.3%,但NSTEMI死亡率自2010年以来趋于稳定。
要点
- STEMI患者6个月死亡率从1995年17.2%降至2015年5.3%,NSTEMI从17.2%降至6.3%。
- STEMI直接PCI从1995年12%增至2015年76%,NSTEMI 72小时内PCI从9%增至60%。
- NSTEMI患者6个月死亡率自2010年以来未见进一步下降。
核心结论
- 过去20年急性心肌梗死6个月死亡率在STEMI和NSTEMI患者中均显著下降。
- STEMI患者死亡率持续下降至2015年,而NSTEMI患者死亡率自2010年以来似趋于稳定。
研究设计与样本
- 基于法国FAST-MI项目5个每5年一次、每次为期1个月的注册登记,覆盖1995至2015年。
- 共纳入14 423例急性心肌梗死患者(59%为STEMI),均为法国本土心脏重症监护病房收治。
主要发现
- STEMI患者平均年龄从66±14岁降至63±14岁,NSTEMI患者维持在68±14岁,糖尿病、肥胖和高血压增加。
- STEMI直接PCI从1995年12%增至2015年76%,NSTEMI入院72小时内PCI从9%增至60%。
- STEMI患者6个月死亡率从1995年17.2%降至2010年6.9%和2015年5.3%。
- NSTEMI患者6个月死亡率从17.2%降至2010年6.9%和2015年6.3%。
- 2010年后,未接受再灌注治疗的STEMI患者死亡率仍下降,而接受再灌注治疗的STEMI患者及NSTEMI患者(无论是否接受PCI)未见进一步死亡率获益。
临床怎么用
- 应持续优化STEMI再灌注策略以维持死亡率下降趋势。
- NSTEMI患者死亡率自2010年以来趋于稳定,需关注其管理模式的进一步改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: ST-segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI) management has evolved considerably over the past 2 decades. Little information on mortality trends in the most recent years is available. We assessed trends in characteristics, treatments, and outcomes for acute myocardial infarction in France between 1995 and 2015. METHODS: We used data from 5 one-month registries, conducted 5 years apart, from 1995 to 2015, including 14 423 patients with acute myocardial infarction (59% STEMI) admitted to cardiac intensive care units in metropolitan France. RESULTS: From 1995 to 2015, mean age decreased from 66±14 to 63±14 years in patients with STEMI; it remained stable (68±14 years) in patients with NSTEMI, whereas diabetes mellitus, obesity, and hypertension increased. At the acute stage, intended primary percutaneous coronary intervention increased from 12% (1995) to 76% (2015) in patients with STEMI. In patients with NSTEMI, percutaneous coronary intervention ≤72 hours from admission increased from 9% (1995) to 60% (2015). Six-month mortality consistently decreased in patients with STEMI from 17.2% in 1995 to 6.9% in 2010 and 5.3% in 2015; it decreased from 17.2% to 6.9% in 2010 and 6.3% in 2015 in patients with NSTEMI. Mortality still decreased after 2010 in patients with STEMI without reperfusion therapy, whereas no further mortality gain was found in patients with STEMI with reperfusion therapy or in patients with NSTEMI, whether or not they were treated with percutaneous coronary intervention. CONCLUSIONS: Over the past 20 years, 6-month mortality after acute myocardial infarction has decreased considerably for patients with STEMI and NSTEMI. Mortality figures continued to decline in patients with STEMI until 2015, whereas mortality in patients with NSTEMI appears stable since 2010.
引用
- Puymirat E, Simon T, Cayla G, et al. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation. 2017. PMID: 28844989. doi:10.1161/CIRCULATIONAHA.117.030798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。